Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Urgency on results and into market

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Jan 12, 2021 4:09pm

137 Views

Post# 32278502

RE:RE:RE:RE:RE:RE:RE:RE:Urgency on results and into market

NamesJeb wrote:
I can't speak for others, but I just exercised mine. If you let them expire you lose everything you paid for them initially.

That's true for all other than those that got them for free in the PP. They can sell and make a few bucks, or exercise and pay a few bucks or just say what the hel and let them expire. Each to his own.
Thanks.

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record